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1. INTRODUCTION
Ionizing radiation (IR) is omnipresent and exposure to 
low background radiation is inevitable. The natural sources 
of exposure range from the Earth’s crust generated radon 
exposure to cosmic radiation. Artificial sources of IR mainly 
comprise medical, industrial and research applications but the 
exposure level is very low. On average, we are exposed to a 
few mSv/year of background radiation and depending on the 
geographical location, it may range from 1 to 10 mSv/year 
and can reach up to 50 mSv/year. Kerala in India and places 
in Brazil, Sudan and Iran have higher background radiation 
ranging from 15- 40 mSv/year1.
In today’s times, there is always a threat of terrorist 
activities involving radiation exposure devices (RED), radiation 
dispersal devices (RDD) or improvised nuclear devices (IND) 
and possible radiation exposure from nuclear reactor accidents 
or lost radioactive sources. Highly penetrating IR deposits 
energy to biomolecules (DNA, proteins and lipids) and cause 
a wide range of structural changes. Damages to genetic 
material, in turn, cause dysfunction in cells, tissues and organs. 
External contamination by radioactive dust can damage skin 
and if ingested, these radioactive materials deposit internally 
in bone and other tissues causing irreversible local injuries. 
Possibilities of such radiation exposure exist at accident sites 
and work environment with radiation sources. Clinical signs 
and symptoms do not occur at the low dose range (<0.1 Gy) 
however, possibilities of health problems can increase in 
subsequent years of exposure.  Since the discovery of radiation 
in 1895 by Roentgen, radiation accidents of different scales have 
occurred with nuclear accidents of Chernobyl, now in Ukraine 
(1986) and   Fukushima, Japan (2011) being of the highest scale. 
These accidents caused radiation emergencies involving few 
hundreds to lakhs of individuals.  Health monitoring of such a 
large population involved screening using radiation detection 
equipment like handheld dosimeters, whole-body counters, 
thyroid scanners and even high-end isotope detection systems 
for body fluids. Individuals suspected of exposure were further 
assessed using various cytogenetic assays including dicentric 
chromosomal assay (DCA)2.  In such scenarios, biodosimetry 
plays a central role along with physical and clinical dosimetry 
for medical management. Radiation emergency is manifested 
in two ways: 
Amount of activity released in the environment and • 
Doses received by individuals. • 
In practice, area monitoring by remote-controlled 
systems including gamma-ray spectrometers is used to assess 
by following the guidelines published in the ‘users manual’ 
of IAEA3  and related documents. The primary purpose of 
radiation emergency assessment is to predict deterministic 
health effects on the size of the population in the vicinity 
of accident or incident sites. The scale of nuclear radiation 
emergency is decided by IAEA, Vienna. According to Swartz 
et al4 during any radiological emergency following types of 
exposure scenarios are possible:
Large-scale radiation event:•  Regulatory agencies of 
countries use varying scales for considering large-scale 
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events that may range from exposure of 100 and more 
people3. As the medical machinery is expected to be 
overwhelmed in such a scenario, the most imperative 
requirement is to segregate suspected individuals based 
on triage for assisting medical management.  Accidents 
of Chernobyl, now in Ukraine, and Fukushima, Japan 
required the evacuation of a few lakhs of the population 
from the sites of the accident. Historically, these two 
accidents were of the highest scale according to the 
guideline of the International Nuclear Event Scale. 
Medical management comprised of various investigations 
related to radiation contaminations including internally 
deposited radioisotopes and clinical signs and symptoms. 
In a radiological accident at Goiania, Brazil more than one 
lakh people were screened for radioactive contamination2. 
These processes continued for months to years after the 
accident. 
Small-scale radiation event: It may involve exposure of very • 
few to  < 100 individuals. These are mainly the radiation 
accidents that have formed the basis of biodosimetry in 
the past4. In such a scenario it is convenient to medically 
assist all the potentially exposed individuals.  
Exposure concentrating on long-term effects: • 
Biodosimetry is an effective tool to assess low dose 
exposures and segregate individuals that do not require 
immediate medical attention (radiation dose ≤ 1Gy, whole 
body). However, in this case, the dose received could 
be possibly sufficient to warrant a long-term follow-up. 
Individuals requiring urgent medical care (radiation dose 
≥1Gy) would also be observed for long term effects. 
Physiological perturbations are likely to manifest at 48 - 
72 hours in individuals exposed to doses > 0.7Gy.
2. NECESSITy Of BIODOSImETRy
In the event of radiation exposure, there are three possible 
ways to determine the exposure status of an individual: 
Physical dose reconstruction using physical dosimeters at • 
sites, 
Clinical assessment using blood cell counts and other • 
physiological symptoms like nausea, vomiting and 
diarrhea 
Biodosimetry for confirmation of radiation exposure and • 
dose assessment. 
Biodosimetry relies on the quantifiable biological 
endpoints occurring due to the interaction of ionizing radiation 
with the biological matter and can be utilised to predict clinically 
relevant doses. Among various biological indicators formation 
of dicentric chromosomes is specific to radiation and sensitive 
to doses and therefore recommended for biodosimetry2. 
In any accident, it is not expected that the affected 
public would be wearing physical dosimeters or their prior 
exposure status would be available. Moreover, the clinical 
signs and symptoms of radiation exposure (primarily 
nausea, vomiting and diarrhea) are not exclusive to IR. In 
such a situation, biodosimetry becomes the only reliable 
medical management tool to estimate the exposure status of 
individuals. During any radiological calamity, a combination 
of physical dosimetry, medical signs and symptoms, a record 
of the individual’s location, hematology and evaluation with 
established biodosimetric methods are used for long term risk 
assessment5.
2.1  Conventional Biodosimetry
Biodosimetric dose assessments have been utilised for 
decades in various major accidents from Chernobyl (1986) 
to Fukushima Daiichi (2011). International Atomic Energy 
Agency (IAEA) manual 20112  has enlisted cytogenetic 
assays like DCA, Cytokinesis Blocked Micronucleus Assay 
(CBMNA), Premature Chromosome Condensation (PCC) and 
Fluorescence in situ hybridisation (FISH) as key techniques for 
biodosimetry. 
With increasing evidence of radiation overexposures 
amongst patients, occupational workers and rising nuclear 
threats after the 2001 incident, US FDA has issued guidance 
for the development of biodosimetry devices. Accordingly, 
the clinically relevant radiation levels could be 2- 10 Gy and 
DCA has an upper limit of 5 Gy for dose detection. DCA is 
considered as the reigning “gold-standard” by IAEA and WHO. 
The low background frequency of the dicentric chromosome 
and the range of dose detection (0.1- 5 Gy) make it a method 
of choice for global biodosimetry laboratories.  However, like 
other cytogenetics-based assays, DCA is completely manual 
and time-intensive where the dose estimation can only be 
made after a minimum of three days. Moreover, DCA requires 
skilled and qualified scorers, which poses major limitations for 
radiation dose assessment in a crisis.
Other important techniques like the gamma-H2AX foci 
assay, electron paramagnetic resonance, or mechanisation 
of existing techniques are rapid to use but necessitate cost-
intensive equipment and large facilities6-7.
2.2  Advances in Biodosimetry
With the possible threat of a probable radiological 
or nuclear event, there is an urgent need to develop new 
technologies and countermeasures for managing any large scale 
population exposure possibilities. Post 11th Sept 2011 attack 
on World Trade Centre, USA, various programs are directed 
towards strengthening the capability and capacity in dealing 
with radiological terrorism. Biodosimetry laboratories started 
expanding in terms of networking and automation. After a 
decade of research, DCA remains the gold standard. However, 
conventional DCA requires extensive manual microscopy 
for detection and quantitation of dicentric frequency.  With 
the availability of automatic image acquisition using Metafar 
microscope and similar systems, capturing of metaphase 
spreads of a few hundred in one slide to few thousand 
metaphases in multiple slides is possible. Romm et al8,9  have 
established and validated semi-automated scoring of dicentric 
chromosomes under the MULTIBIODOSE EU FP7 project 
with six participating laboratories establishing semi-automated 
dose-response calibration curves. Machine learning and 
artificial intelligence approaches have substantially increased 
the efficiency in terms of speed and accuracy. For example, the 
time taken for analyzing 150 metaphases using this approach 
was effectively reduced to few minutes as compared to taking 
60 minutes by manual scoring of 50 metaphases8,9. Different 
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approaches for metaphase image analysis are being considered 
at other laboratories including ours. 
David Brenner’s group at Columbia University has 
developed Rapid automated tools based on CBMNA and 
phosphorylation of Histone (γ H2AX).6,10,11 Robya et al., 
recently developed Rapid Automated Biodosimetry Tool 
II (RABiT-II) robotic system that utilises an improvised 
centromere FISH protocol and the entire assay is performed 
exclusively on an automated system11.  RABiT-II can process 
multiple samples utilizing multiwell plates, thus making it 
useful for triage applications. In an attempt to increase the 
sample analysis capacity, a miniaturised adaptation using a 96-
microtube template, a “mini-DCA” was established with semi-
automated DCA scoring that reduced the sample handling and 
analysis time by a factor of 4, along with analyzing a large 
number of samples together12. 
Despite advances in semi-automatic image-based dicentric 
analysis and the possibility of complete automation DCA will 
not be able to serve the purpose of triage, as it cannot negate 
the requirement of stimulation of lymphocytes and culturing, 
thus requiring at least 2-3 days before the results could be 
available. DCA also requires an off-site laboratory setting and 
thus cannot be utilised as a point-of-care diagnostic.
Radiation biodosimetry is emerging beyond its preliminary 
objectives and identifying strategies that may be employed 
for mass screening. Novel biological markers of radiation 
injury, utilizing the “omics” approach in the field of genomics, 
proteomics, transcriptomics and metabolomics are taking center 
stage for giving a new dimension to conventional biodosimetry. 
Sullivan et al5 critically reviewed the different biodosimetry 
approaches including conventional DCA, CBMNA, gamma-
H2AX foci assay and “-omic” assays. These novel “omics” 
based dosimeters utilise a varied class of molecules like 
DNA, mRNA, miRNA, protein expression and metabolomic 
profiles, exploiting different technology platforms. All these 
prospective markers are minimally invasive and are mostly 
investigated in blood, serum, plasma, saliva, or urine; which 
can be readily acquired in field settings, making them a good 
candidate for point-of-care diagnostic possibility. The current 
mini-review focuses on “gene expression-based biodosimetry” 
as a promising new approach that can overcome the limitations 
of existing cytogenetic assays.
3. GENE ExpRESSION BASED 
BIODOSImETRy
Environmental stresses including IR triggers numerous 
signal transduction pathways, consequentially generating 
multiple gene expression changes, which could be utilised 
as one of the most potential assays to analyse the effect of 
radiation on the cell. Studies have developed gene expression-
based radiation exposure signatures in ex vivo  irradiated human 
peripheral blood13-15, in vivo using blood from total body 
irradiated (TBI) patients14,16-17, isolated human monocytes18, 
CD4+ lymphocytes19, biopsy samples20-21 and human cell 
lines22-23.  The method relies on identifying the radiation 
responsive genes that preferentially transcribe in response to 
ionizing radiation.
3.1  Approaches used in Genomics-based 
Biodosimetry
Based upon the technologies involved a majority of the 
gene expression-based biodosimetry studies have utilised two 
major platforms:
3.1.1 Whole-genome Microarray-based Method
 A large number of studies utilised whole-genome 
microarray studies to identify radiation responsive panel 
of genes13-14,24-25. Macaeva and co-workers analysed the 
response of 0, 0.1, 1 Gy radiation doses on ex vivo irradiated 
human peripheral blood mononuclear cells (PBMCs), where 
the radiation responsive differential gene signatures were 
transcribed and dose predicting genes were identified25. They 
also utilised exon-specific qRT-PCR approach to demonstrate 
the alternate splicing of many candidate biomarker genes upon 
radiation exposure and demonstrated that expression of highly 
responsive exons might have a better predictive significance 
especially at higher doses of about 1 Gy as compared to genes, 
where expression signals of the exons of these genes become 
averaged25.
Using a similar approach, a 74-gene signature 
discriminating radiation doses from a low dose range of 0.5 
Gy to a very high dose range of 8 Gy was identified, where 
a majority of these genes were regulated by transcription 
factor p53. Nearest Centroid classifier was used to accurately 
distinguish 98 per cent of samples at six or twenty-four hour 
time points as exposed or non-exposed13. A meta-analysis 
comparing eleven microarray studies identified a 29-gene 
signature forecasting high (>8Gy) and low (<2Gy) radiation 
exposure26. Lacombe and co-workers compared 24 microarray 
studies in a meta-analysis to quantify gene expression levels in 
human blood exposed to ionizing radiation ex-vivo or in-vivo 
with 10,170 unique genes and the twenty-seven genes were 
common in half of the studies and TNFSF4, FDXR, MYC, 
ZMAT3 and GADD45A specifically had the greatest diagnostic 
potential of discriminating radiation dose < 2Gy and dose ≥ 
2Gy27.
FDXR (Ferredoxin Reductase) especially scores as a 
biodosimetry marker of radiation-induced transcriptional 
changes both as a candidate gene and as part of the validation 
panel of genes17,27-28. Using the candidate gene approach, 
O’Brien et al., systematically analysed FDXR and presented 
its in vivo dose-response at very low doses and found a strong 
correlation between physical and biological dose estimates, thus 
concluding it as a strong gene radiation marker29. Participating 
laboratories of the European Union’s Realizing the European 
Network of Biodosimetry project (EU-RENEB) analysed gene 
expression profiles both in vivo and ex vivo in blood samples 
of prostate cancer patients and healthy volunteers respectively 
and demonstrated that dose estimates of FXDR were similar, 
regardless of the methodology adopted by the laboratories, 
implying that the approach adopted for blood incubation did 
not affect results17.
3.1.2  Reverse Transcription-Polymerase Chain Reaction 
(qRT-PCR) Based Method
qRT-PCR candidate gene biodosimetry is the most 
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sensitive technique for the detection and quantification of 
gene expression levels and is a reliable biodosimetry tool. 
Majority of the studies focused on genes related to DNA repair, 
apoptosis and cell cycle checkpoints in different models like 
mice, radiotherapy patients and ex vivo human blood30,31,32,33.
3.2 Radiation Responsive Genes
Different studies have utilised various bioinformatics 
approaches to identify a set of genes that are differentially 
modulated upon radiation exposure. Literature survey revealed 
more than 10,000 differentially altered genes in response to 
radiation where different dose rates, time points, doses, ex vivo, 
in vivo irradiation and other variables are evaluated13-15,17,24-
25,27,34.  A common aspect in the majority of these studies is the 
activation of tumor suppressor p53 target genes across a cross-
section of parameters. p53 is a DNA-binding transcription 
factor that plays a key role in cellular adaptation to stress like 
ionizing radiation exposure. It regulates the transcription of 
genes in various pathways including DNA repair, cell cycle 
checkpoint, or apoptosis, thus maintaining genome integrity. 
An account of the key genes projected as radiation 
biomarkers in some of the studies that focussed primarily on 
human blood irradiated with X-rays or γ rays and genes validated 
by qRT-PCR are summarised in Annexure I. This mini-review 
comprehends a limited number of studies and for an extensive 
list of genes, other detailed reviews are suggested.27,35
3.3 merits of Genomics Based Biodosimetry
Many efforts have been made to advance biodosimetry 
using end-points that can offer dose assessments rapidly with 
better sample throughput. Studies have recommended the 
advancement of gene-expression based radiation biodosimetry 
as a promising alternative approach to conventional 
methodologies15,25,35,38,40-42. This approach is minimally invasive 
where whole blood can be used for biomarker discovery. 
Analyzing gene expression does not require cell division, which 
is the main time-consuming process in performing assays like 
DCA and CBMNA, thus making it a rapid technique. In case 
of any radiological emergency, gene expression assays can 
be performed easily utilizing qRT-PCR which is available in 
most biomedical research laboratories. Gene signatures in 
peripheral blood can differentiate irradiated and nonirradiated 
samples without having the prerequisite of having a matching 
pre-exposure sample and thus is considered a potent tool in 
biodosimetry assay advancement13. With current advancements 
in high throughput gene expression screening, it is promising 
to develop gene expression signatures that correlate with 
the timing and dose of radiation exposures. Another recent 
study addressed the temporal gene expression responses and 
RNA extraction methodologies to be utilised in emergency 
situations39. More such studies are needed to correlate 
these responses in vivo and generate sufficient data for this 
methodology to be useful in the triage of potentially exposed 
populations. 
Despite the non-homogeneous nature of the transcriptional 
response in 24 studies analysed as a systematic review by 
Lacombe et al., an evident p53-regulated response was 
observed, suggesting the involvement of p53-mediated 
pathways such as DNA damage repair, cell cycle regulation 
and apoptosis27. Similar patterns can be observed in studies 
listed in Annexure I.
Radiation responsive gene signatures can be practically 
helpful for mass screening using microfluidics and “lab-on-
chip” technology,43,44,45  as a robust field-deployable point-of-
care high throughput device that can analyse large numbers of 
samples quickly.
3.4  Limitations of Genomics Based Biodosimetry 
Several large-scale studies have utilised gene expression-
based biodosimetry for dose prediction. However, there is 
inconsistency in reproducing results for identified biomarkers27. 
The possible explanation for the encountered variation could 
be the usage of non-homogenous microarray platforms, 
different experimental practices like radiation sources varying 
doses, time points, dose rates and divergent bioinformatics 
and statistical approaches. A limited sample size of patients 
studied also restricts the parameters for direct comparisons. 
Inter-individual variations, age and gender-based variations 
and other stresses like disease state and smoking status16 also 
play a vital role in gene responses to radiation. To counter 
these limitations, always a panel of radiation responsive gene 
biomarkers should be used that cater to wider variables to 
improve their performance.
The extremely dynamic and transitory nature of gene 
expression signals is one of the major limitations of using 
this assay as a radiation exposure biomarker. To understand 
the kinetics of expression of the panel of candidate genes, it 
is pivotal to have prior knowledge of their baseline expression 
and accurate time of exposure while assessing the dose.  Direct 
validation in radiotherapy patients may cause limitation with 
pre-existing diseases like cancer and could be a source of 
interference while analyzing gene expression. However, inter-
lab comparisons with harmonised protocols are necessary for 
biodosimetry laboratories.
4. fUTURE AREAS Of ADvANCEmENT
To circumvent the limited accessibility of human samples 
to study radiation stress responses across a range of doses, 
a humanised mouse model was used as in vivo model for 
gene expression biodosimetry using engrafted human cells45. 
A recent study proposed IR induced extended presence of 
stable circular RNAs (circRNAs) in p53-dependent genes 
(Pvt1, Ano3, Sec14l5, and Rnf169) in embryonic mouse brain, 
primary cortical neurons and blood. These circRNAs were 
independently regulated as compared to linear mRNAs and 
since the radiation-induced expression of mRNAs rapidly 
reduces, some circRNAs remain stable or persistently rise for 
a longer window of time, making them durable transcription 
exploratory markers46. The single-cell RNA sequencing 
(scRNA-seq) is used in cancer cell biology48 and to determine 
intricate regulatory interactions between genes49  and warrants 
further exploration for radiation response pathways in diverse 
cell subsets. 
Further studies on larger population sizes that include 
a wide range of ages, ethnicities and lifestyles, along with 
information of the physical dose received will assess inter-
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individual variations coherently, giving insights into individual 
radiation sensitivity. These insights could be useful in long-term 
epidemiological assessment after a large-scale radiological 
event. Similarly, this information could be useful for clinical 
radiation oncology in assessing long-term outcomes like 
carcinogenesis. 
Other important areas for exploration could be the gene 
expression responses to partial body irradiation50, internal 
contamination and combined injuries, different dose-rates and 
qualities of radiation. Correlation with established assays in an 
accredited lab will also add more reliability to this assay, thus 
making gene expression-based biodosimetry an indispensable 
tool for future applications.
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